NxStage Medical Reports Fourth Quarter and Full Year 20...(41457 - Other assets ...),Health

Other assets 2,057 406

Total assets $210,386 $101,725

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $21,887 $5,917

Accrued expenses 9,874 4,104

Due to affiliates 2,774 -

Current portion of long-term debt - 2,800

Total current liabilities 34,535 12,821

Deferred revenue 19,530 229

Long-term debt 25,000 4,617

Other long term obligations 1,604 649

Total liabilities 80,669 18,316

Commitments and contingencies - -

Stockholders' equity:

Common stock: par value $0.001,

100,000,000 shares authorized:

36,771,893 and 27,806,543 shares

issued and outstanding as of December 31,

2007 and December 31, 2006, respectively 37 28

Additional paid-in capital 311,172 206,848

Accumulated deficit (182,036) (123,640)

Accumulated other comprehensive income 544 173

Total stockholders' equity 129,717 83,409

Total liabilities and stockholders'

equity $210,386 $101,725

NxStage Medical, Inc.

Revenue by Market

Three Months Ended Twelve Months Ended

December 31,
'/>"/>